Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Transurban (TCL.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-03-30	13.31	14.90	Buy
2022-06-21	13.95	15.35	Buy
2022-10-21	12.34	15.20	Buy
2023-02-08	14.06	15.45	Buy
2023-08-17	13.18	15.35	Buy
2023-10-20	11.97	14.50	Buy
2024-02-02	13.41	14.80	Buy
2024-07-17	12.97	14.60	Buy
2024-10-23	13.05	14.55	Buy
2024-12-11	13.00	14.75	Buy
2025-02-21	13.15	14.85	Buy
2025-04-17	13.86	14.60	Neutral

Disclosures

Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.